Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Niacin Stories

2013-02-18 23:21:29

Société´s Triple C Serum delivers the most stable and highest concentration of Vitamin C in the world Atlanta, GA (PRWEB) February 18, 2013 You have to “C” it to believe it. Until now, a more acidic form of Vitamin C has traditionally been delivered in a lower pH product, causing irritation and limiting consumer use. Société Clinical Skincare´s newest product, Triple C Serum, combines the three most stable forms of Vitamin C available in a...

2013-02-12 11:55:09

Study finds African-American, Caucasian women absorb, metabolize vitamin D at same rate African-American women battling vitamin D deficiencies need the same dose as Caucasian women to treat the condition, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). Although women with darker skin tones tend to have lower levels of the biomarker used to measure Vitamin D levels, called 25-hydroxyvitamin D or...

2013-02-05 12:27:43

MAPLE GROVE, Minn., Feb. 5, 2013 /PRNewswire/ -- February is American Heart Month, a month dedicated to spreading awareness and accurate information about healthy heart choices. For many, maintaining good cholesterol (HDL) within the normal range is an important factor in heart health. There are many factors that can impact cholesterol, including genetics and lifestyle habits, such as obesity or poor diet. In addition to smart eating and regular exercise, a cardiologist may recommend a...

2013-01-18 12:22:33

TAMPA, Fla., Jan. 18, 2013 /PRNewswire-iReach/ -- In a controlled study the Riordan Clinic Researchers purposely created individual vitamin b deficiencies in rats in order to study the outcome. B vitamins are available only through diet or supplementation since the body cannot create it. They have long been associated with better memory and cognitive abilities, metabolic function, energy and cell formation but what are the results of individual deficiencies? (Photo:...

2012-12-28 05:02:49

HealthyAnswers.com is a publisher and a leader in providing current natural health information on their website. Along with thousands of archived articles on health related issues, they also offer a complimentary health newsletter, quality nutritional solutions, and self improvement books. Delray Beach, FL (PRWEB) December 27, 2012 Cardiovascular disease is the #1 killer of both men and women in the United States today, but that doesn´t have to be the case, says HealthyAnswers.com. In...

2012-12-13 12:24:49

MAPLE GROVE, Minn., Dec. 13, 2012 /PRNewswire/ -- Maintaining high-density lipoprotein (HDL) within the normal range is an important factor in maintaining heart health. HDL cholesterol is also known as "good cholesterol" because it is thought to help move cholesterol out of the arteries and into the liver so the body can get rid of it. Nicotinic acid is a type of B vitamin that occurs naturally and is clinically proven to support HDL, but due to the nature of its name, consumers in need of...

2012-11-29 12:29:18

MAPLE GROVE, Minn., Nov. 29, 2012 /PRNewswire/ -- Doctors often recommend dietary supplement niacin to help maintain good cholesterol, also known as HDL, in the normal range; however, there are so many options on pharmacy shelves, many of which are not clinically proven to support heart health. Dr. Carl Lavie, Medical Director, Cardiac Rehabilitation and Prevention at the John Ochsner Heart and Vascular Institute, New Orleans, LA, has been recommending dietary supplement niacin for over two...

2012-11-07 16:26:52

BOSTON, Nov. 7, 2012 /PRNewswire/ -- ARI-3037MO was well tolerated in single and repeat ascending dose trials in healthy volunteers ARI-3037MO did not provoke flushing or any other treatment-related adverse effects in 58 healthy male and female volunteers ARI-3037MO was well absorbed orally and plasma levels demonstrated good dose proportionality ARI-3037MO showed encouraging lipid changes in both clinical trials in healthy subjects Arisaph Pharmaceuticals, Inc. announced today during...

2012-11-05 08:32:10

PARIS and TARRYTOWN, N.Y., Nov. 5, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the ODYSSEY OUTCOMES trial, a Phase 3 cardiovascular outcomes trial (CVOT) with SAR236553/REGN727 is now recruiting patients. SAR236553/REGN727 is an investigational subcutaneously administered, fully-human antibody that is being evaluated for its impact on lowering low-density lipoprotein cholesterol (LDL-C) by targeting PCSK9...

2012-11-02 07:27:36

PRINCETON, N.J., Nov. 2, 2012 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, today announced an invitation to attend the presentation of data from its Phase 3 clinical studies. The presentation will be held on November 5, 2012 at 7:30 a.m. pst in the Bernards Room at the Millennium Biltmore Hotel, 506 South Grand Avenue, Los Angeles. Participants are also invited to attend the presentation via a live webcast available through the "What's...